BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
Orano Med expands its Texas Pb-212 R&D center
Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated the expansion of its main research and development center located in Plano, Texas. The...
Canada clears Darlington to produce Lu-177 and Y-90
The Canadian Nuclear Safety Commission has amended Ontario Power Generation’s power reactor operating license for Darlington nuclear power plant to authorize the production of the medical...
Oak Ridge’s Isotek dramatically increases world supply of Th-229
Workers with Oak Ridge Office of Environmental Management contractor Isotek have surpassed a significant milestone in the supply of medical radioisotopes, extracting more than 15 grams of rare...
ANS holds Educator Training webinar on nuclear waste
A recent American Nuclear Society webinar tackled misconceptions about nuclear waste. Christopher Perfetti, an associate professor of nuclear engineering at the University of New Mexico,...
SHINE to acquire Lantheus’s SPECT business line
SHINE Technologies, a fusion company building what is set to be the world’s largest medical isotope production facility at its Wisconsin campus, announced that it has agreed to acquire the...
Nuclear's future discussed at MURR expansion
ANS Executive Director/CEO Craig Piercy recently spoke on nuclear power’s potential for answering today’s energy demands as part of the Distinguished Lecture Series at the University of...
Framatome, IBA to develop At-211 production network in Europe and U.S.
French nuclear energy company Framatome and Belgian particle accelerator technology company Ion Beam Applications (IBA) have signed a memorandum of understanding to advance the...
Oklo plans to acquire radioisotope firm Atomic Alchemy for $25 million in shares
Oklo Inc. has that it has signed a letter of intent to acquire Atomic Alchemy Inc., a U.S.-based radioisotope production company. The two companies announced a strategic partnership earlier...
Framatome to produce Lu-177 at Romania’s Cernavoda
Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at...
TerraPower reaches market-scale production of Ac-225
TerraPower Isotopes, a subsidiary of Bellevue, Wash.–based TerraPower, announced it is now producing actinium-225 at commercial scale, making the medical isotope available to the...
